Nirav Ratia

Effects of a topical treatment with spleen tyrosine kinase inhibitor in healthy subjects and patients with cold urticaria or chronic spontaneous urticaria: Results of a phase 1a/b randomised double‐blind placebo‐controlled study

O. Dewit, M. Maurer, M. Metz, 2021, British journal of clinical pharmacology.

Advanced imaging for quantification of abnormalities in the salivary glands of patients with primary Sjögren’s syndrome

G. Searle, L. Kershaw, Coziana Ciurtin, 2020, Rheumatology.

Safety, pharmacokinetics and pharmacodynamics of a topical SYK inhibitor in cutaneous lupus erythematosus: A double‐blind Phase Ib study

J. Wenzel, M. Worm, T. Schneider-Merck, 2020, Experimental dermatology.

Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors

James D. Clarke, A. El-Khoueiry, B. Tran, 2023, British Journal of Cancer.

DREAMM-5 Study: Investigating the Synergetic Effects of Belantamab Mafodotin Plus Inducible T-Cell Co-Stimulator Agonist (aICOS) Combination Therapy in Patients with Relapsed/Refractory Multiple Myeloma

S. Trudel, P. Richardson, N. Callander, 2021, Blood.